Fig. 4
From: Leukocyte telomere length serves as the novel prognostic biomarker for the resectable NSCLC
Po-LTL predicts the prognosis of resectable NSCLC. Kaplan-Meier OS (A) and DFS (B) analysis with Po-LTL using log-rank test. Univariate (C) and multivariate analysis of NSCLC patients based on COX regression mode.
